TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 50 filers reported holding TALARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $245,735 | +321.0% | 8,745 | -54.5% | 0.00% | – |
| Q2 2023 | $58,365 | +48.2% | 19,199 | -8.4% | 0.00% | – |
| Q1 2023 | $39,395 | -3.2% | 20,955 | -47.5% | 0.00% | – |
| Q4 2022 | $40,682 | -52.1% | 39,884 | +23.4% | 0.00% | – |
| Q3 2022 | $85,000 | -22.7% | 32,314 | +32.3% | 0.00% | – |
| Q2 2022 | $110,000 | -54.9% | 24,425 | -1.6% | 0.00% | – |
| Q1 2022 | $244,000 | -30.9% | 24,821 | +7.5% | 0.00% | – |
| Q4 2021 | $353,000 | – | 23,088 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $7,713,000 | 11.20% |
| Aisling Capital Management LP | 175,000 | $460,000 | 0.30% |
| Artal Group S.A. | 2,064,262 | $5,429,000 | 0.23% |
| Cormorant Asset Management, LP | 900,649 | $2,369,000 | 0.17% |
| Eventide Asset Management | 1,561,092 | $4,106,000 | 0.08% |
| Blackstone Inc. | 8,089,315 | $21,275 | 0.08% |
| Logos Global Management LP | 197,913 | $521,000 | 0.06% |
| Values First Advisors, Inc. | 30,715 | $81,000 | 0.06% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $8,652,000 | 0.04% |
| CAAS CAPITAL MANAGEMENT LP | 297,707 | $783,000 | 0.04% |